Prevalence and association of major coronary risk factors with CAD: Single centre study  by Sambasivam, K.A. et al.
Conclusion: Our study suggests that thrombolytic therapy is a
reasonable option for reperfusion therapy even in case of ST
elevation MI presenting after window period, with a lower rate of
periprocedural complication, as compared to PCI.
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alone on saephenous vein graft patency after
coronary artery bypass graft surgery e an
angiographic follow-up after three months
O.S. Thopte, S.P. Patil, R.S. Deshmukh
Sri Sathya Sai Institute of Higher Medical Sciences, Prashanthigram, AP,
India
Background: The co-administration aspirin-clopidogrel results in
enhancement of platelet inhibition and would improve outcomes
after CABG in terms of graft patency and major adverse cardio-
vascular events.
Objectives: The objective of this study was to examine the clinical
efficacy of clopidogrel treatment on saphenous vein graft patency,
incidence of major adverse cardiovascular events and safety
following CABG at the end of 3 months.
MethodsandResults: In this study, 74patientsundergoing coronary
arterybypassgraftingwithSVGswere randomized toreceiveaspirin
150 mg plus clopidogrel 75 mg daily or aspirin 150 mg plus placebo
daily for 3months. The primary outcomewas saphenous vein graft
patency as determined coronary angiography at 3 months. Sec-
ondary outcomes were major adverse cardiovascular events, and
major bleeding. At the end of 3 months coronary angiography was
performed in 66 patients (89.1%). Overall 3month SVG graft patency
was 95.2% in the aspirin-clopidogrel group compared with 82.1% in
the aspirin-placebo group (P¼0.007), and LIMApatencywas 97.1% in
the aspirin-clopidogrel group versus 96.9% in the aspirin-placebo
group (P¼1.000). Freedomfrommajor adverse cardiovascular events
at 3 months was similar for the 2 groups. The incidence of major
bleeding at 3 months was similar for the 2 groups (8.8 versus 6.25%,
aspirin-clopidogrel versus aspirin-placebo, P¼1.000).
Conclusions: Compared with aspirin monotherapy, the combi-
nation of aspirin plus clopidogrel did significantly improve SVG
patency 3 months after coronary artery bypass grafting without
increasing the risk of major bleeding complications.
Demographic, clinical profile and intermediate-
term clinical outcomes of ostial and ostioproximal
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Background: Ostial and ostioproximal stenting have traditionally
been considered complex interventions and higher rate of reste-
nosis was seen in the BMS era. After the advent of DES, though
restenostic rates have come to single figures, most authoritative
guidelines recommend surgical recourse for ostial lesions due to
higher rates of reinterventions and TLR. This retrospective anal-
ysis was conducted at a tertiary care referral centre in South India
to determine intermediate term clinical outcomes and rates of
clinical restenosis at 9th-month follow up.
Methods: Patients who serially underwent coronary intervention
for ostial and/or ostioproximal lesions between Jan 1, 2011 and
Dec 31, 2012 at SSSIHMS Bangalore were studied for their symp-
toms, functional status, comorbidities and echocardiographic
parameters, including LVEF. The demographic parameters
including the age, gender and risk factors, the clinical presenta-
tion and profile, as also the angioplasty details including the stent
deployment data were collected at baseline. At 9th month follow-
up a clinical assessment and echocardiographic follow-up was
conducted.
Results: 72 patients (males¼44, females¼28) underwent PCI in the
above period, of whom 9th month clinical and echocardiographic
follow-up was available in 47 patients (67.4 %). The arteries
intervened upon in ostial location were: LAD in 42, RCA in 23, LCX
in 5, LPDA in 1,and major OM in 1.Two patients had combined
proximal RCA and op LAD stenting. Implanted stents were: DES:
45 and BMS 32 (mainly due to compelling indications). Average
stent size was 3.15 ± 1.35 mm, length-21 mm ± 2.1 mm. In all
LMCA to opLAD stenting proximal flaring of the stent was
performed.
On follow-up at 9 months : in the 47 (36/ 54 ACS : 11/18 SIHD),
patients on follow-up, good compliance with medication was
noted. At least 4 patients had recurrent ACS and underwent a
repeat stenting at our Institute and two definite stent thrombosis
occurred during hospital course.6 patients were referred for CABG
due to ISR and recurrence of symptoms, of whom poor drug and
DAPT compliance was noted in 3 patients. 8 of these 12 patients
had stenting from the initial ACS arm. Excluding these, therefore
35 patients reported as being asymptomatic and return of
acceptable quality of life .Of the 36 ACS ,21 ACS had no change or
fall in LVEF but angina grade improved by at least one grade, in 15
LVEF improved by at least 5 % with improvement in angina,( P
¼0.069 ). The delay in referral from occurrence of ACS to perfor-
mance of PCI could explain the lack of improvement in ACS pa-
tients undergoing ostial PCI.7/11 patients with SIHD had a
preserved LVEF and improvement in angina, 4 patients with SIHD
continued to have symptoms of lower grade of angina and were
managed medically ( P<0.01 for improvement after PCI).
Conclusion: We inferred from our analysis that ostial stenting in
ACS led to improvement in anginal symptoms at intermediate
term follow-up with no significant objective improvement in LVEF
especially in patients with DM; however in SIHD significant
improvement in clinical symptoms with less recurrent events
(less clinical restenosis) supports the feasibility of ostial stenting
in this situation.
Prevalence and association of major coronary risk
factors with CAD: Single centre study
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Background: Different studies in our country on risk factor prev-
alence and association with CAD have shown varying picture. No
major large scale study has been done in this part of the country.
Methods: This is a retrospective cross sectional observational
study. We collected data from inpatient and outpatient records
between 1995 and 2010. Data were collected with respect to
presence of DM, HT, Smoking and levels of TC, HDL, LDL & TG and
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presence of CAD based on angio or documented MI.. There were
11250 patients, we divided the cohort in to 2 Groups, namely, CAD
+ (Group 1) and CAD e (Group 2).
Results: Group-wise comparison showed the following Results:
Mean age in Group I significantly higher. (56.36 Vs 52.95) p z
0.0000. There were significantly higher number of males in Group
1. (6125 Vs 2682) p z 0.0000. DM (41.5%Vs 21.8%) p z 0.0000.
Smoking (13.1%Vs 5.7%) p z0.0000 were significantly higher in
Group 1. Mean HDL was significantly lower in Group 1. (39.42 Vs
41.75), p z 0.0000.
Stepwise logistic regression was done on 10,615 patients which
showed the following.
From the logistic regression analysis, adjusted for TC, TC/HDL,
HDL/LDL, HDL and HTN it is observed that:
CAD risk 3.037 times higher in males and 2.535 times higher in
DM, 2.107 times higher in smokers, 1.029 times higher with each
unit increase in Age. Not adjusting for Gender, analysis showed
CAD risk is 2.458 times higher in DM and 2.751 times higher in
smokers. Using Logistic regression model we found that in a 55
year old male, presence of diabetes increases the risk further by
18.82% and presence of smoking further increases by 9.15%.
Conclusion: 1) Traditional risk factors as age, DM, smoking have
significant association with CAD. 02) Average lipoprotein levels
were lower in our population.
High dose statin study
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Background: There has been no Indian data on high dose statin in
our country.
Aims: To assess the tolerability and safety (A 80) in high risk
patients.
Methods: This is a retrospective observational study. 272
consecutive patients who were prescribed A80 and could be fol-
lowed for 2 years formed the cohort. Data were retrieved from
inpatient and outpatient records. Baseline demographics, initial
diagnosis, interventional procedure done, list of concomitant
medications, side effect profile, reason for dose reduction were all
obtained and analysed.
Results: There were 238 males (87.5%) & 34 females (12.5%) Mean
age was 56.4 year. HT was seen in 119 (43.75 %). DM in 109 (40.07%)
Dyslipidemia in 114 (41.9 %) Tobacco use in 75 (27.57%) 236 (86.7%)
patients presented with acute coronary syndrome. 204 (75 %)
STEMI; 17 (6.25%) NSTEMI and 14with unstable angina: (5.14%) 116
patients had 2VD on CAG. Mean TC 186, HDL 36.01, LDL 119, TG
143; Mean reduction in LDL was 49.3% in six months. 83 (30.51%)
patients had their dose reduction for various reasons. Maximal
reduction was seen in first six months, [(49/83). 62%]. 35 patients
had dose reduction due to financial reasons (43%). 29 patients had
dose reduction without any reason in the case file (34%). 15 pa-
tients had dose reduction due to side effects (18.07%). Cough was
seen in 4 (1.47%), Abdominal pain 2 (0.735%), Constipation in 3
(1.10%), Headache in 3 (1.10%) and Tiredness in 1, necessitating
dose reduction. One each had SGPT and CK elevation requiring
dose reduction. CK elevation more than 10 times was seen in one
patient requiring stopping the statin.
Conclusion: High dose statin therapy (A80) is safe, tolerable with
minimal side effects and should be prescribed to all deserving
patients similar to our study group.
Our experience of CTO angioplasties
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Background: Chronic total occlusion is defined as complete oc-
clusion of the coronary vessel with TIMI O flow, present for an
estimated duration of >3 months. Studies have found a frequency
of 15-20% of CTO in angiographies. Chronic total occlusion PCI has
experienced significant growth in the last few years with the
adaptation and refinement of advanced techniques.
Methods: Over the past 3 years, more than 250 CTO PTCA were
performed at ourcentre. We present an analysis of these CTO
PTCA done at our centre. Subjects were analysed with respect to
demographics, presentation, outcome and material used.
Results: Of the patients, males composed 72 % and females 28 % of
patients. The predominant presentation was chronic stable
angina (42%) followed by unstable angina (24%) and NSTEMI. The
average LV function was 45%, while viability of myocardium was
confirmed with stress thallium scans. The vessels involved were
LAD: 38%, RCA: 42%, and LCX: 20%. In 82% procedures, TIMI III flow
could be established without any complications. 12% procedures
were unsuccessful, primarily due to inability to cross the lesion.
Complications occured in 15 % of CTO PTCA. Of these, the com-
monest was: flap formation (7%). Perforation occured in 6% of
patients, of which 2 required placement of a covered stent, while
the others were managed by balloon occlusion. 2% patients
required pericardial tapping. Contrast induced nephropathy
occured in 1 patient, while 4 patients succumbed in the peri-
procedural period. 64% of the lesions were negotiated using reg-
ular angioplasty wires (our workhorse FIELDER FC PTCA wires),
while 36% required use of CTO wires.
Conclusion: CTO PTCA is one of the final frontiers of coronary
interventions, our experience shows that CTO PTCA shows
promising results, with complications rates that are progressively
diminishing. We would like to highlight that a majority CTO PTCA
were carried out using regular angioplasty wires with balloon
support as opposed to CTO wires.
Role of erythrocytes in coronary artery disease
Janapati Ramakrishna, M. Jyotsna, D. Seshagiri Rao
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Background: Association of Red blood cell distribution width
(RDW) and coronary artery disease (CAD) is well established. But
other erythrocyte parameters Mean corpuscular volume (MCV),
Mean corpuscular Haemoglobin (MCH), Mean corpuscular hae-
moglobin concentration (MCHC) importance in pathogenesis of
CAD is not studied.
Methods: Retrospective analysis of 765 patients’ records (with
complete Haemogram), who underwent coronary angiogram for
suspected CAD in yearr 2013 at a tertiary care hospital were
included in this study. Patients were grouped into angiography
positive (AGP) (N¼438), angiography negative (AGN) (N¼327) based
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